Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0000905148-25-001058

Options or other derivatives

  • Former EVP, CFO & COO returned 13,838 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hyllengren Eric J Former EVP, CFO & COO 2025-03-31 Returned to the company · Employee Stock Option (Right to Buy) −1,900 0 D
Hyllengren Eric J Former EVP, CFO & COO 2025-03-31 Returned to the company · Employee Stock Option (Right to Buy) −460 0 D
Hyllengren Eric J Former EVP, CFO & COO 2025-03-31 Returned to the company · Employee Stock Option (Right to Buy) −496 0 D
Hyllengren Eric J Former EVP, CFO & COO 2025-03-31 Returned to the company · Employee Stock Option (Right to Buy) −154 0 D
Hyllengren Eric J Former EVP, CFO & COO 2025-03-31 Returned to the company · Employee Stock Option (Right to Buy) −381 0 D
Hyllengren Eric J Former EVP, CFO & COO 2025-03-31 Returned to the company · Employee Stock Option (Right to Buy) −350 0 D
Hyllengren Eric J Former EVP, CFO & COO 2025-03-31 Returned to the company · Employee Stock Option (Right to Buy) −262 0 D
Hyllengren Eric J Former EVP, CFO & COO 2025-03-31 Returned to the company · Employee Stock Option (Right to Buy) −543 160 D
Hyllengren Eric J Former EVP, CFO & COO 2025-03-31 Returned to the company · Employee Stock Option (Right to Buy) −331 0 D
Hyllengren Eric J Former EVP, CFO & COO 2025-03-31 Returned to the company · Employee Stock Option (Right to Buy) −8,961 2,656 D
Loading xslF345X05/form4.xml…